Information needs of patients considering oral immunotherapy for food allergy
File(s)
Accepted version
Supporting information
Author(s)
Type
Journal Article
Abstract
While the historic management of food allergy includes avoidance strategies and allergic reaction treatment, oral immunotherapy (OIT) approaches have become more commonly integrated into therapeutic approaches. International guidelines, phase 3 trials and real-world experience have supported the implementation of this procedure. However, OIT is an elective, rarely curative procedure with inherent risks that necessitates an increased degree of health literacy for the patients and families. Families assume the responsibility of amateur health care providers to ensure the daily safe administration of the allergenic food. As such, it is incumbent upon physicians to ensure that families are prepared for this role. A thorough educational and shared decision-making approach is necessary during the counseling and consent process to adequately inform the families. Educated discussion about the efficacy and patient-centred effectiveness, therapeutic alternatives, and family goals is required to align physician and patient expectations. A frank discussion about the struggles, practical challenges, risks and contraindications can help to develop an understanding of the risk mitigation strategies employed to maintain safety. Physicians should develop a proactive approach to educate families about this, at times, burdensome procedure. This educational approach should encourage ongoing support starting prior to consent through the maintenance visits. By preparing families for their unique management role, physicians can help ensure the safe and successful integration of OIT into the therapeutic offering for the management of food allergies.
Date Issued
2022-12
Date Acceptance
2022-09-06
Citation
Clinical and Experimental Allergy, 2022, 52 (12), pp.1391-1402
ISSN
0954-7894
Publisher
Wiley
Start Page
1391
End Page
1402
Journal / Book Title
Clinical and Experimental Allergy
Volume
52
Issue
12
Copyright Statement
© 2022 John Wiley & Sons Ltd. This is the peer reviewed version of the following article: Mack, DP, Greenhawt, M, Turner, PJ, et al. Information needs of patients considering oral immunotherapy for food allergy. Clin Exp Allergy. 2022; 52: 1391- 1402, which has been published in final form at https://doi.org/10.1111/cea.14225. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
Identifier
https://onlinelibrary.wiley.com/doi/10.1111/cea.14225
Publication Status
Published
Date Publish Online
2022-09-09